ASTANA, Kazakhstan, January 22. Kazakhstan is
set to build four new pharmaceutical plants, Trend reports via the Kazakh
government.


The government has approved investment agreements between the
Ministry of Health of Kazakhstan and the companies AltINPHARM,
MSP-ROMPHARM, Abdi Ibrahim Global Pharm, and Nobel Almaty
Pharmaceutical Factory for the localization of pharmaceutical
production. The total investment in the approved projects amounts
to 173 billion tenge ($340 million).


The corresponding resolutions were signed by Prime Minister
Olzhas Bektenov.


The implementation of these projects involves the localization
of production for 356 types of medicines, including socially
significant drugs. The product range will cover medications for
cancer and diabetes treatment, as well as immunobiological,
antiviral, anti-anemia, pain-relieving, anti-inflammatory, cold and
flu, and antimicrobial medicines.


The new plants will be located in Almaty (two projects), as well
as in the Turkestan and Almaty regions.


In particular, the AltINPHARM project will involve the
construction of a pharmaceutical plant in the Special Economic Zone
"Park of Innovative Technologies" in Almaty.







The Nobel Almaty Pharmaceutical Factory project also plans the
construction of a pharmaceutical complex in Almaty for the
production of active pharmaceutical ingredients, medicines, and
biopharmaceuticals.


The Abdi Ibrahim Global Pharm project will establish a
pharmaceutical complex with multi-profile production lines in the
Almaty region.


The MSP-ROMPHARM project involves the construction of a
high-tech pharmaceutical plant in the TURAN Special Economic Zone
in the Turkestan region.


Kazakhstan's pharmaceutical sector includes 207 manufacturers as
of mid-2025, up from 193 in 2023. This count features 43 medicine
producers (25 with GMP certification) and 164 medical device
manufacturers. Domestic production surged in 2024, bolstered by
government initiatives favoring local output through long-term
contracts and import substitution strategies. Key production
regions include Shymkent, Almaty city, the Almaty region, and the
Karaganda region.


Stay up-to-date with more news on Trend News
Agency's WhatsApp channel